U.S. pharma huge copyright scrapped two experimental weight loss supplements last year—a at the time-everyday capsule, lotiglipron, resulting from elevated liver enzymes in addition to a twice-everyday capsule, danuglipron, as a consequence of potent side effects—but CEO Albert Bourla has said the company is set to “Perform and gain” from t